← Every company
United Therapeutics Corp Patents
What United Therapeutics Corp has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
UTHR on carbonthat →Filings on file
44
Granted
5
Still pending
39
Filed under
2 names
44 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| METHODS FOR PREPARING, STORING, AND TRANSPORTING A NATIVE OR ENGINEERED ORGAN FOR TRANSPLANTFiled as UNITED THERAPEUTICS CORPORATION2026-03-10CHRISTOPHER GIVENS | pending |
| METHODS FOR PREPARING, STORING, AND TRANSPORTING A NATIVE OR ENGINEERED ORGAN FOR TRANSPLANTA01N 1/10, A01N 1/162, A01N 1/122, A01N 1/126, A01N 1/146, A01N 1/165Filed as United Therapeutics Corporation2026-03-10Christopher Givens | pending |
| MOTORIZED SYRINGE ASSISTANCE DEVICE AND METHOD OF USE THEREOFA61J 1/2055, A61M 5/1782, A61J 1/201, A61J 1/2065, A61J 1/2096, A61J 1/22, A61M2005/3114, A61M2205/123, A61M2209/045Filed as United Therapeutics Corporation2026-02-27Avi Azoulay | pending |
| MOTORIZED SYRINGE ASSISTANCE DEVICE AND METHOD OF USE THEREOFFiled as UNITED THERAPEUTICS CORPORATION2026-02-27AVI AZOULAY | pending |
| SYSTEM AND METHOD FOR MAINTAINING ORGAN VIABILITYA01N 1/142, A01N 1/143, A01N 1/146, A01N 1/148, A01N 1/144, A01N 1/165, C12N 5/0602Filed as United Therapeutics Corporation2026-01-16Randolph Vernon Monteiro Shelton | pending |
| TREATMENT FOR INTERSTITIAL LUNG DISEASEA61K 31/192, A61K 31/5575, A61P 9/12, A61P 11/00, A61K 9/007, A61K 9/0075, A61K 9/0078Filed as United Therapeutics Corporation2025-12-15Leigh Peterson | 12697315 |
| TREPROSTINIL FORMULATIONS AND THEIR USESFiled as UNITED THERAPEUTICS CORPORATION2025-12-12HITESH BATRA | pending |
| TREPROSTINIL FORMULATIONS AND THEIR USESA61K 9/0073, A61K 31/5575, A61P 11/00, A61K 9/0078, A61K 9/08, A61K 31/5578, A61K 47/02, A61K 47/10, A61K 47/186, A61K2300/00Filed as United Therapeutics Corporation2025-12-12Hitesh Batra | pending |
| TREATMENT FOR INTERSTITIAL LUNG DISEASEA61K 31/192, A61K 31/5575, A61P 9/12, A61P 11/00, A61K 9/007, A61K 9/0075, A61K 9/0078Filed as United Therapeutics Corporation2025-11-25Leigh Peterson | 12740954 |
| TREATMENT FOR INTERSTITIAL LUNG DISEASEA61K 31/192, A61K 31/5575, A61P 9/12, A61P 11/00, A61K 9/007, A61K 9/0075, A61K 9/0078Filed as United Therapeutics Corporation2025-11-25Leigh Peterson | 12734143 |
| TREPROSTINIL PRODRUGSA61K 31/222, A61K 31/27, A61P 9/12, A61P 11/00, A61K 9/0019, A61K 9/0021, A61K 9/0053, A61K 31/195, A61K 31/216, A61K 31/221, A61K 31/265, A61K 31/335Filed as United Therapeutics Corporation2025-11-18Ken Phares | pending |
| STABLE TREPROSTINIL PRODRUGSA61K 31/192, A61K 31/216, A61K 31/5575, A61P 9/12, A61K 9/0053, A61K 9/08, A61K 31/222, A61K 31/225, A61K 31/335, A61K 31/6615Filed as United Therapeutics Corporation2025-11-14Kenneth Robert Phares | pending |
| AUTOMATED BIOREACTOR SYSTEM, SYSTEM FOR AUTOMATICALLY IMPLEMENTING PROTOCOL FOR DECELLULARIZING ORGAN, AND WASTE DECONTAMINATION SYSTEMA01N 1/143, A61L2103/05, A61L 2/022, A61L 27/36, G01G 19/00, G01K 13/02, G01L 7/00Filed as United Therapeutics Corporation2025-10-10Ryan Bonvillain | pending |
| RALINEPAG PRODRUGS AND USES THEREOFA61P 9/12, C07C 271/28, C07C2601/14, A61K 31/325, A61K 31/357, A61K 31/4545, A61K 31/5375, C07B2200/07, C07C 311/51, C07D 211/32, C07D 211/58, C07D 295/185, C07D 295/195, C07D 317/40Filed as United Therapeutics Corporation2025-10-02Hitesh BATRA | pending |
| TREATING PULMONARY HYPERTENSION BASED ON NOVEL BIOMARKERFiled as UNITED THERAPEUTICS CORPORATION2025-08-05KENTA TAKAHASHI | pending |
| TREATING PULMONARY HYPERTENSION BASED ON NOVEL BIOMARKERA61K 31/192, A61K 31/5575, A61P 11/00, A61K 9/0073, G01N 33/6884, G01N2333/46, G01N2800/52Filed as United Therapeutics Corporation2025-08-05Kenta Takahashi | pending |
| STRUCTURAL FEATURES OF A VEHICLE HAVING UTILITY TO TRANSPORT HIGH VALUE THINGSB64C 1/061, B64U 50/14, B64U 60/50, B64U2101/60, B64D 27/402, B64D 27/40, B64C 25/06, B64C 29/0033, B64C2001/0045, Y02T 50/10Filed as United Therapeutics Corporation2025-07-29Ty Christopher Sauer | pending |
| PRE-CONDITIONED EXTRACELLULAR VESICLES AND METHODS OF PRODUCTIONA61K 35/12, A61K 35/28, A61K2035/124, C12N 5/0031, C12N 5/0663, C12N 5/0665, C12N2501/2306, C12N2501/24, C12N2501/25, C12N2513/00Filed as United Therapeutics Corporation2025-07-11Pamela Tiet | pending |
| METHODS FOR PREPARING, STORING, AND TRANSPORTING A NATIVE OR ENGINEERED ORGAN FOR TRANSPLANTFiled as United Therapeutics Corporation2025-03-11Christopher Givens | pending |
| METHODS OF MAKING IP-RECEPTOR AGONISTSFiled as UNITED THERAPEUTICS CORPORATION2025-03-10HITESH BATRA | pending |
| METHODS OF MAKING IP-RECEPTOR AGONISTSC07C 269/06, C07C 271/28Filed as United Therapeutics Corporation2025-03-10Hitesh Batra | pending |
| MOTORIZED SYRINGE ASSISTANCE DEVICE AND METHOD OF USE THEREOFFiled as United Therapeutics Corporation2025-02-28Avi Azoulay | pending |
| TREPROSTINIL PRODRUGSA61P 9/00, C07D 211/46, C07D 295/185, C07F 9/65744, C07C2603/74, C07C2603/14, A61P 11/06, A61P 25/02, A61P 9/12, A61P 13/12, A61P 9/04, A61P 11/00, A61K 9/0019, A61K 9/0053, A61K 45/06, C07C 59/72, C07C 405/0083, C07D 207/16, C07D 211/58, C07D 211/60, C07D 265/30, C07D 295/088, C07D 317/40, C07D 321/12, C07F 9/09, C07F 9/091, C07F 9/093, C07F 9/117Filed as United Therapeutics Corporation2024-12-23Kenneth Robert Phares | pending |
| TREPROSTINIL FORMULATIONS AND THEIR USESFiled as United Therapeutics Corporation2024-12-13Hitesh Batra | pending |
| SYNTHESES OF COMPOUNDS USEFUL FOR PRODUCING TREPROSTINILFiled as UNITED THERAPEUTICS CORPORATION2024-11-08HITESH BATRA | pending |
| SYNTHESES OF COMPOUNDS USEFUL FOR PRODUCING TREPROSTINILC07C 29/095, C07C 51/36, C07C2603/14, B01J 31/003, C07B2200/07, C07C 29/143, C07C 29/36, C07C 29/42, C07C 29/56, C07C 31/36, C07C 33/042, C07C 45/29, C07C 49/207, C07C2523/46, C07F 7/083, C12P 7/04, C12Y 101/01Filed as United Therapeutics Corporation2024-11-08Hitesh Batra | pending |
| TREPROSTINIL DERIVATIVES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONSA61K 9/0075, A61K 9/14, A61K 9/1617, A61K 47/542, A61P 9/12, A61K 31/495, A61K 31/5575, A61K 45/06, A61K2300/00Filed as United Therapeutics Corporation2024-11-04Hitesh Batra | pending |
| CONTAINER AND METHOD FOR PRESERVING OR TRANSPORTING BIOLOGICAL MATERIALSFiled as UNITED THERAPEUTICS CORPORATION2024-10-24SIMONE JULIE GREGOR | pending |
| REPAIR OF ENDOTHELIAL GLYCOCALYXFiled as UNITED THERAPEUTICS CORPORATION2024-10-16SARAH HOGAN | pending |
| REPAIR OF ENDOTHELIAL GLYCOCALYXA01N 1/126, A61K 31/728, A61P 11/00, A61K 31/198, A61K 31/726, A61K 31/727, A61K 31/737, A61K 38/49, A61K2300/00, C12Y 304/21068Filed as United Therapeutics Corporation2024-10-16Sarah Hogan | pending |
| SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVESC07C 45/64, C07C 45/673, C07C 67/31, C07C 67/343, C07C2603/14, C07C 45/67, C07C 45/78, C07C 45/81, C07C 47/565, C07C 47/575, C07C 67/333, C07C 69/84, C07C 69/92Filed as United Therapeutics Corporation2024-09-16Hitesh Batra | pending |
| CRYSTALLINE PROSTACYCLIN (IP) RECEPTOR AGONIST AND USES THEREOFA61P 9/12, C07C 271/28, C07C2601/14, A61K 31/325, C07B2200/13, C07C 269/08Filed as United Therapeutics Corporation2024-08-19Kenneth PHARES | pending |
| A METHOD OF PRODUCING AN ORAL OSMOTIC PHARMACEUTICAL DELIVERY SYSTEM AND A PHARMACEUTICAL BATCH PRODUCED USING THE SAMEFiled as UNITED THERAPEUTICS CORPORATION2024-08-07COURTNEY CHANG | pending |
| METHOD OF PRODUCING AN ORAL OSMOTIC PHARMACEUTICAL DELIVERY SYSTEM AND A PHARMACEUTICAL BATCH PRODUCED USING THE SAMEA61K 9/0004, A61K 31/192, A61K 9/2054, A61K 9/2866, A61K 9/2886, A61K 9/2893, A61K 31/5575Filed as United Therapeutics Corporation2024-08-07Courtney Chang | pending |
| TREATING PULMONARY HYPERTENSION BASED ON NOVEL BIOMARKERFiled as United Therapeutics Corporation2024-08-06Kenta Takahashi | pending |
| CONTROLLED RELEASE PHARMACEUTICAL FORMULATIONSC07C 69/708, C07C2603/14, A61P 27/02, A61P 7/02, A61P 9/10, A61P 9/00, A61P 9/12, A61P 13/12, A61P 11/00, A61P 15/00, A61P 25/00, A61P 29/00, A61P 35/00, A61K 31/5575, A61K 31/558, C07C 67/08Filed as United Therapeutics Corporation2024-06-24Peter LAING | pending |
| AUTOMATED BIOREACTOR SYSTEM, SYSTEM FOR AUTOMATICALLY IMPLEMENTING PROTOCOL FOR DECELLULARIZING ORGAN, AND WASTE DECONTAMINATION SYSTEMA01N 1/143, A61L2103/05, A61L 2/022, A61L 27/36, G01G 19/00, G01K 13/02, G01L 7/00Filed as United Therapeutics Corporation2024-05-31Ryan Bonvillain | 12458015 |
| SALTS OF TREPROSTINILA61P 9/12, C07C 51/41, A61K 31/19, C07C 51/412, C07C 59/72Filed as United Therapeutics Corporation2024-04-15Hitesh BATRA | 12709592 |
| METHODS OF MAKING IP-RECEPTOR AGONISTSFiled as United Therapeutics Corporation2024-03-11Hitesh Batra | pending |
| TREATMENT FOR INTERSTITIAL LUNG DISEASEA61K 31/192, A61K 31/5575, A61P 9/12, A61P 11/00, A61K 9/007, A61K 9/0075, A61K 9/0078Filed as United Therapeutics Corporation2024-02-23Leigh Peterson | pending |
| TREATMENT OF PULMONARY ARTERIAL HYPERTENSIONFiled as UNITED THERAPEUTICS CORPORATION2024-01-18GIL GOLDEN | pending |
| TREPROSTINIL ANALOGS AND RELATED METHODS OF MAKING AND USINGA61K 31/222, C07C 59/72, C07C 69/675, C07F 9/095, C07C2603/14, A61K 31/661, C07B2200/07, C07C 59/70, C07C 59/90, C07C 69/63, C07C 69/712, C07C 69/90, C07F 7/1804, C07F 9/091, C07H 15/24Filed as United Therapeutics Corporation2024-01-18Hitesh Batra | pending |
| TREPROSTINIL ANALOGS AND RELATED METHODS OF MAKING AND USINGFiled as UNITED THERAPEUTICS CORPORATION2024-01-18HITESH BATRA | pending |
| TREATMENT OF PULMONARY ARTERIAL HYPERTENSIONA61K 31/192, A61K 31/5575, A61K 31/5585, A61P 9/12, A61K 9/0053, A61K 31/343Filed as United Therapeutics Corporation2024-01-18Gil Golden | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on UTHR
Company overviewEverything on UTHR in one place, with the price.SEC filingsWhat UTHR's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat UTHR's own officers and directors buy and sell.Planned salesSales UTHR insiders have filed notice of.Executive payWhat UTHR awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in UTHR.Funds holding itWhich funds and ETFs hold UTHR, and how big a bet.LobbyingWhat UTHR spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on UTHR's account, and who they worked for.Federal contractsWhat federal agencies pay UTHR.AircraftThe jets on UTHR's registration.